Cash flow DSM-Firmenich

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 2026-01-16			5-day change	1st Jan Change
66.60 ^CHF	-2.46%		-1.77%	-3.14%

01-14	DSM-Firmenich AG Announces Executive and Committee Changes	CI
01-14	DSM-Firmenich Names New Chief Human Resources Officer	MT

c8.gdYp5mvn5KmHRe1fizS4aSgaDVNli6j-Q02ylumiwis.8pFq3h2DtcvxEYw65lnMBBFQSDsPzv3KDxzh46HaunvpkViDEY2un94rjg

Published financial data: DSM-FIRMENICH

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.11B	9.2B	8.39B	10.63B	12.8B
Total Revenues	8.11B	9.2B	8.39B	10.63B	12.8B
Cost of Goods Sold, Total	5.33B	6.04B	5.7B	8.02B	8.55B
Gross Profit	2.78B	3.16B	2.69B	2.61B	4.24B
Selling General & Admin Expenses, Total	1.62B	1.79B	1.77B	2.54B	2.85B
R&D Expenses	398M	323M	295M	652M	888M
Other Operating Expenses	84M	29M	-29M	-16M	0
Other Operating Expenses, Total	2.1B	2.14B	2.04B	3.17B	3.74B
Operating Income	672M	1.02B	652M	-560M	509M
Interest Expense, Total	-90M	-92M	-104M	-138M	-162M
Interest And Investment Income	17M	3M	22M	95M	70M
Net Interest Expenses	-73M	-89M	-82M	-43M	-92M
Income (Loss) On Equity Invest.	-64M	16M	12M	-6M	-5M
Currency Exchange Gains (Loss)	-22M	-7M	-20M	-86M	-41M
Other Non Operating Income (Expenses)	14M	-15M	-1M	-26M	1M
EBT, Excl. Unusual Items	527M	928M	561M	-721M	372M
Merger & Related Restructuring Charges	-55M	-25M	-3M	-59M	-39M
Gain (Loss) On Sale Of Investments	32M	326M	-7M	-1M	5M
Gain (Loss) On Sale Of Assets	-	13M	31M	17M	47M
Insurance Settlements	29M	11M	12M	53M	21M
Legal Settlements	23M	2M	-	-	-
Other Unusual Items	7M	2M	5M	57M	21M
EBT, Incl. Unusual Items	563M	1.26B	599M	-654M	427M
Income Tax Expense	106M	168M	124M	-18M	147M
Earnings From Continuing Operations	457M	1.09B	475M	-636M	280M
Earnings Of Discontinued Operations	51M	591M	1.24B	2.79B	-
Net Income to Company	508M	1.68B	1.72B	2.15B	280M
Minority Interest	-2M	-4M	-15M	-16M	-30M
Net Income - (IS)	506M	1.68B	1.7B	2.14B	250M
Preferred Dividend and Other Adjustments	7M	6M	6M	6M	-
Net Income to Common Incl Extra Items	499M	1.67B	1.69B	2.13B	250M
Net Income to Common Excl. Extra Items	448M	1.08B	454M	-658M	250M
Per Share Items
Net EPS - Basic	2.91	9.67	9.8	9.14	0.94
Basic EPS - Continuing Operations	2.61	6.25	2.63	-2.82	0.94
Basic Weighted Average Shares Outstanding	172M	173M	173M	233M	265M
Net EPS - Diluted	2.89	9.63	9.77	9.14	0.94
Diluted EPS - Continuing Operations	2.59	6.22	2.61	-2.82	0.94
Diluted Weighted Average Shares Outstanding	172M	173M	173M	233M	265M
Normalized Basic EPS	1.91	3.34	1.94	-2	0.77
Normalized Diluted EPS	1.9	3.32	1.94	-2	0.77
Dividend Per Share	2.4	2.5	2.53	2.5	2.5
Payout Ratio	57.11	15.87	20.29	7.35	264
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.21B	1.62B	1.23B	352M	1.6B
EBITA	865M	1.24B	892M	-83M	1.12B
EBIT	672M	1.02B	652M	-560M	509M
Effective Tax Rate - (Ratio)	18.83	13.37	20.7	2.75	34.43
Total Current Taxes	145M	122M	107M	188M	324M
Total Deferred Taxes	-39M	46M	17M	-206M	-177M
Normalized Net Income	327M	576M	336M	-467M	202M
Interest Capitalized	6M	4M	3M	4M	6M
Interest on Long-Term Debt	6M	5M	6M	8M	15M
Non-Cash Pension Expense	4M	-7M	1M	7M	9M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.15B	1.27B	1.24B	1.51B	1.8B
General and Administrative Expenses	469M	517M	534M	1.02B	1.04B
Research And Development Expense From Footnotes	507M	334M	295M	652M	888M
Stock-Based Comp., Other (Total)	29M	22M	35M	29M	35M
Total Stock-Based Compensation	29M	22M	35M	29M	35M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	871M	1.56B	2.76B	2.46B	2.67B
Short Term Investments	43M	489M	125M	107M	50M
Total Cash And Short Term Investments	914M	2.05B	2.88B	2.56B	2.72B
Accounts Receivable, Total	1.39B	1.6B	1.51B	2.55B	2.59B
Other Receivables	76M	88M	78M	220M	145M
Notes Receivable	16M	-	24M	69M	23M
Total Receivables	1.48B	1.69B	1.61B	2.84B	2.76B
Inventory	1.88B	2.3B	2.34B	3.39B	3.29B
Other Current Assets, Total	1.15B	91M	1.3B	49M	35M
Total Current Assets	5.42B	6.13B	8.13B	8.84B	8.8B
Gross Property Plant And Equipment	7.89B	8.69B	7.44B	9.97B	10.18B
Accumulated Depreciation	-4.12B	-4.73B	-3.87B	-4.42B	-4.45B
Net Property Plant And Equipment	3.77B	3.96B	3.58B	5.55B	5.72B
Long-term Investments	321M	259M	196M	721M	568M
Goodwill	2.52B	2.95B	2.98B	11.29B	11.25B
Other Intangibles, Total	1.94B	2.36B	2.16B	7.44B	6.83B
Loans Receivable Long-Term	4M	1M	2M	11M	54M
Deferred Tax Assets Long-Term	239M	203M	95M	228M	299M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	146M	154M	259M	179M	224M
Total Assets	14.36B	16.01B	17.4B	34.27B	33.75B
Liabilities
Accounts Payable, Total	1.21B	1.56B	1.41B	2.06B	2.27B
Accrued Expenses, Total	393M	414M	345M	584M	643M
Short-term Borrowings	55M	44M	30M	31M	173M
Current Portion of Long-Term Debt	7M	13M	14M	604M	573M
Current Portion of Leases	47M	48M	44M	84M	90M
Current Income Taxes Payable	53M	77M	64M	177M	223M
Unearned Revenue Current, Total	11M	10M	4M	8M	5M
Other Current Liabilities	491M	264M	668M	968M	382M
Total Current Liabilities	2.26B	2.43B	2.58B	4.52B	4.36B
Long-Term Debt	3.31B	2.84B	2.84B	3.78B	4.01B
Long-Term Leases	168M	147M	135M	331M	434M
Unearned Revenue Non Current	76M	62M	55M	70M	63M
Pension & Other Post Retirement Benefits	450M	358M	266M	520M	487M
Deferred Tax Liability Non Current	433M	485M	476M	1.75B	1.56B
Other Non Current Liabilities	175M	291M	203M	226M	140M
Total Liabilities	6.88B	6.62B	6.56B	11.2B	11.05B
Common Stock, Total	338M	328M	328M	3M	3M
Additional Paid In Capital	489M	471M	471M	11.73B	11.31B
Retained Earnings	7.79B	8.54B	9.78B	10.74B	10.63B
Treasury Stock	-976M	-177M	-196M	-44M	-147M
Comprehensive Income and Other	-243M	156M	363M	474M	710M
Total Common Equity	7.4B	9.32B	10.74B	22.91B	22.51B
Minority Interest	88M	79M	102M	162M	186M
Total Equity	7.49B	9.4B	10.84B	23.07B	22.7B
Total Liabilities And Equity	14.36B	16.01B	17.4B	34.27B	33.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	172M	173M	173M	265M	264M
ECS Total Common Shares Outstanding	172M	173M	173M	265M	264M
Book Value / Share	42.96	53.87	62.07	86.35	85.18
Tangible Book Value	2.94B	4.01B	5.6B	4.17B	4.43B
Tangible Book Value Per Share	17.09	23.17	32.33	15.72	16.77
Total Debt	3.59B	3.09B	3.07B	4.83B	5.28B
Net Debt	2.67B	1.04B	186M	2.27B	2.56B
Debt Equivalent of Unfunded Proj. Benefit Obligation	434M	248M	104M	309M	265M
Minority Interest, Total (Incl. Fin. Div)	88M	79M	102M	162M	186M
Equity Method Investments, Total	93M	64M	61M	130M	342M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	491M	621M	596M	1.02B	926M
Inventories - Work In Process, Total	1.47B	1.76B	1.81B	2.45B	2.48B
Land - (BS)	2.1B	2.11B	1.93B	2.96B	2.88B
Machinery, Total	4.97B	5.71B	4.62B	5.64B	5.65B
Full Time Employees	21.31K	21.36K	19.26K	28.68K	26.3K
Part Time Employees	-	-	1.42K	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	28M	23M	12M	15M	20M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	508M	1.68B	1.72B	2.15B	250M
Depreciation & Amortization - CF	394M	425M	392M	510M	577M
Amortization of Goodwill and Intangible Assets - (CF)	193M	221M	240M	477M	609M
Depreciation & Amortization, Total	587M	646M	632M	987M	1.19B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	4M	-649M	-1.02B	-2.84B	-47M
Asset Writedown & Restructuring Costs	119M	35M	20M	320M	244M
(Income) Loss On Equity Investments - (CF)	32M	-342M	-5M	7M	-
Stock-Based Compensation (CF)	29M	22M	34M	23M	31M
Net Cash From Discontinued Operations	34M	-	72M	38M	-
Other Operating Activities, Total	156M	179M	18M	422M	-84M
Change In Accounts Receivable	-4M	-194M	-133M	49M	-18M
Change In Inventories	-36M	-323M	-442M	89M	-38M
Change In Accounts Payable	48M	334M	116M	126M	97M
Change in Other Net Operating Assets	17M	39M	-38M	-104M	157M
Cash from Operations	1.49B	1.43B	965M	1.26B	1.78B
Capital Expenditure	-458M	-433M	-506M	-555M	-645M
Sale of Property, Plant, and Equipment	1M	27M	17M	16M	19M
Cash Acquisitions	-1.53B	-704M	-74M	-3.69B	-5M
Divestitures	-2M	1.79B	1.37B	3.53B	42M
Sale (Purchase) of Intangible assets	-168M	-144M	-145M	-137M	-119M
Investment in Marketable and Equity Securities, Total	673M	-365M	360M	40M	432M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-8M	19M	-152M	-2M	-23M
Other Investing Activities, Total	13M	17M	10M	70M	47M
Cash from Investing	-1.48B	208M	876M	-726M	-252M
Short Term Debt Issued, Total	-	12M	-	-	38M
Long-Term Debt Issued, Total	1.12B	37M	51M	15M	833M
Total Debt Issued	1.12B	49M	51M	15M	871M
Short Term Debt Repaid, Total	-95M	-	-21M	-7M	-
Long-Term Debt Repaid, Total	-323M	-567M	-86M	-622M	-733M
Total Debt Repaid	-418M	-567M	-107M	-629M	-733M
Issuance of Common Stock	63M	34M	25M	757M	21M
Repurchase of Common Stock	-309M	-165M	-210M	-256M	-706M
Common Dividends Paid	-	-	-	-151M	-660M
Preferred Dividends Paid	-	-	-	-6M	-
Common & Preferred Stock Dividends Paid	-289M	-266M	-345M	-	-
Common & Preferred Stock Dividends Paid	-289M	-266M	-345M	-157M	-660M
Special Dividend Paid	-	-	-	-425M	-
Other Financing Activities, Total	-87M	-69M	-59M	-125M	-127M
Cash from Financing	83M	-984M	-645M	-820M	-1.33B
Foreign Exchange Rate Adjustments	-24M	39M	-2M	-18M	19M
Net Change in Cash	71M	690M	1.19B	-299M	211M
Supplemental Items
Cash Interest Paid	54M	65M	52M	61M	67M
Cash Income Tax Paid (Refund)	124M	133M	131M	179M	275M
Levered Free Cash Flow	-235M	1.29B	-644M	185M	597M
Unlevered Free Cash Flow	-179M	1.34B	-578M	271M	698M
Change In Net Working Capital	589M	-614M	1B	-297M	77M
Net Debt Issued / Repaid	705M	-518M	-56M	-614M	138M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.02	4.21	2.44	-1.35	0.94
Return on Total Capital	3.89	5.43	3.09	-1.67	1.14
Return On Equity %	5.97	12.9	4.69	-3.75	1.22
Return on Common Equity	5.92	12.91	4.53	-3.91	1.1
Margin Analysis
Gross Profit Margin %	34.25	34.38	32.06	24.57	33.17
SG&A Margin	20.01	19.44	21.12	23.85	22.25
EBITDA Margin %	14.91	17.58	14.71	3.31	12.49
EBITA Margin %	10.67	13.52	10.63	-0.78	8.74
EBIT Margin %	8.29	11.11	7.77	-5.27	3.98
Income From Continuing Operations Margin %	5.64	11.83	5.66	-5.98	2.19
Net Income Margin %	6.24	18.21	20.26	20.11	1.95
Net Avail. For Common Margin %	5.53	11.72	5.41	-6.19	1.95
Normalized Net Income Margin	4.04	6.26	4	-4.39	1.58
Levered Free Cash Flow Margin	-2.9	13.98	-7.67	1.74	4.66
Unlevered Free Cash Flow Margin	-2.21	14.61	-6.9	2.55	5.45
Asset Turnover
Asset Turnover	0.58	0.61	0.5	0.41	0.38
Fixed Assets Turnover	2.07	2.38	2.23	2.33	2.27
Receivables Turnover (Average Receivables)	5.43	6.15	5.39	5.23	4.98
Inventory Turnover (Average Inventory)	2.73	2.89	2.46	2.8	2.56
Short Term Liquidity
Current Ratio	2.4	2.52	3.15	1.96	2.02
Quick Ratio	1.05	1.54	1.73	1.18	1.25
Operating Cash Flow to Current Liabilities	0.66	0.59	0.37	0.28	0.41
Days Sales Outstanding (Average Receivables)	67.34	59.37	67.69	69.74	73.52
Days Outstanding Inventory (Average Inventory)	133.83	126.18	148.43	130.43	142.91
Average Days Payable Outstanding	89.74	78.22	94.46	69.92	96.05
Cash Conversion Cycle (Average Days)	111.44	107.32	121.67	130.25	120.38
Long Term Solvency
Total Debt/Equity	47.92	32.93	28.27	20.95	23.26
Total Debt / Total Capital	32.4	24.77	22.04	17.32	18.87
LT Debt/Equity	46.47	31.81	27.46	17.83	19.58
Long-Term Debt / Total Capital	31.41	23.93	21.41	14.74	15.88
Total Liabilities / Total Assets	47.88	41.32	37.68	32.68	32.74
EBIT / Interest Expense	7.47	11.12	6.27	-4.06	3.14
EBITDA / Interest Expense	13.99	18.14	12.35	3.09	10.46
(EBITDA - Capex) / Interest Expense	8.9	13.43	7.48	-0.93	6.48
Total Debt / EBITDA	2.85	1.85	2.39	11.32	3.12
Net Debt / EBITDA	2.12	0.63	0.14	5.32	1.51
Total Debt / (EBITDA - Capex)	4.48	2.5	3.94	-37.76	5.03
Net Debt / (EBITDA - Capex)	3.34	0.84	0.24	-17.73	2.44
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.35	13.55	15.42	26.66	20.44
Gross Profit, 1 Yr. Growth %	0.43	13.98	2.99	-2.94	62.58
EBITDA, 1 Yr. Growth %	-5.91	33.83	-5.44	-71.47	363.48
EBITA, 1 Yr. Growth %	-11.19	43.82	-4.19	-109.3	-1.45K
EBIT, 1 Yr. Growth %	-16.73	52.23	-8.17	-185.89	-190.89
Earnings From Cont. Operations, 1 Yr. Growth %	-33.67	138.29	-42.77	-233.89	-144.03
Net Income, 1 Yr. Growth %	-33.25	231.23	1.43	25.71	-88.3
Normalized Net Income, 1 Yr. Growth %	-24.57	75.94	-12.48	-239.03	-143.4
Diluted EPS Before Extra, 1 Yr. Growth %	-32.01	139.82	-44.69	-207.91	-133.31
Accounts Receivable, 1 Yr. Growth %	-12.63	15.24	-5.99	69.3	1.41
Inventory, 1 Yr. Growth %	-6.93	22.25	1.83	44.93	-2.95
Net Property, Plant and Equip., 1 Yr. Growth %	-6.58	4.82	-9.79	55.17	3.17
Total Assets, 1 Yr. Growth %	6.85	11.62	8.63	96.92	-1.53
Tangible Book Value, 1 Yr. Growth %	-30.17	35.45	39.59	-25.48	6.31
Common Equity, 1 Yr. Growth %	-4.29	25.94	15.29	113.24	-1.73
Cash From Operations, 1 Yr. Growth %	7.87	-4.48	-32.38	31.09	40.55
Capital Expenditures, 1 Yr. Growth %	-11.92	-5.46	16.86	9.68	16.22
Levered Free Cash Flow, 1 Yr. Growth %	-244.88	-622.59	-159.02	-127.76	235.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-180.49	-807.57	-150.4	-145.13	164.44
Dividend Per Share, 1 Yr. Growth %	0	4.17	1.2	-1.19	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.47	7.27	1.74	20.91	23.51
Gross Profit, 2 Yr. CAGR %	-9.71	6.99	-1.56	-0.02	25.62
EBITDA, 2 Yr. CAGR %	-14.84	12.21	1.03	-48.06	13.83
EBITA, 2 Yr. CAGR %	-19.86	13.01	1.55	-70.14	11.95
EBIT, 2 Yr. CAGR %	-25.45	12.59	-1.5	-11.19	-11.64
Earnings From Cont. Operations, 2 Yr. CAGR %	-34.92	25.72	1.95	-12.46	-23.22
Net Income, 2 Yr. CAGR %	-31.46	48.7	83.29	12.92	-61.65
Normalized Net Income, 2 Yr. CAGR %	-31.45	15.2	1.25	10.31	-22.32
Diluted EPS Before Extra, 2 Yr. CAGR %	-34.57	27.69	0.4	-22.75	-40.04
Accounts Receivable, 2 Yr. CAGR %	-6.02	0.34	4.12	26.16	31.03
Inventory, 2 Yr. CAGR %	-2.9	6.66	11.57	21.48	18.6
Net Property, Plant and Equip., 2 Yr. CAGR %	3.68	-1.03	-2.67	18.32	26.53
Total Assets, 2 Yr. CAGR %	2.62	9.14	10.14	46.26	39.25
Tangible Book Value, 2 Yr. CAGR %	-20.79	-2.5	37.52	1.99	-11
Common Equity, 2 Yr. CAGR %	-2.49	9.79	20.5	56.8	44.76
Cash From Operations, 2 Yr. CAGR %	3.64	1.5	-19.63	-5.85	35.74
Capital Expenditures, 2 Yr. CAGR %	-9.97	-8.75	5.11	13.21	12.9
Levered Free Cash Flow, 2 Yr. CAGR %	-21.01	181.52	61.65	-58.84	-5.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-36.04	145.88	74.49	-51.41	7.82
Dividend Per Share, 2 Yr. CAGR %	2.15	2.06	2.67	0	-0.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-2.07	-0.23	1.61	9.45	20.75
Gross Profit, 3 Yr. CAGR %	-1.82	-2.42	-0.9	-2.02	17.57
EBITDA, 3 Yr. CAGR %	-1.21	-0.99	-1.34	-33.72	7.01
EBITA, 3 Yr. CAGR %	-2.6	-2.62	-2.89	-54.22	6.29
EBIT, 3 Yr. CAGR %	-5.53	-5.42	-6.86	-5.9	-10.5
Earnings From Cont. Operations, 3 Yr. CAGR %	-36.45	0.31	-11.66	11.65	-30.39
Net Income, 3 Yr. CAGR %	-34.11	15.88	30.9	61.64	-46.97
Normalized Net Income, 3 Yr. CAGR %	-3.93	-6.15	-8.21	12.54	-19.17
Diluted EPS Before Extra, 3 Yr. CAGR %	-36.31	0.88	-11.84	2.84	-41.64
Accounts Receivable, 3 Yr. CAGR %	-3.38	0.59	-1.79	22.44	17.3
Inventory, 3 Yr. CAGR %	0.56	4.85	5.03	21.74	12.72
Net Property, Plant and Equip., 3 Yr. CAGR %	4.44	4.07	-3.99	13.7	13.04
Total Assets, 3 Yr. CAGR %	3.91	5.49	8.99	33.68	28.19
Tangible Book Value, 3 Yr. CAGR %	-8.98	-5.12	9.9	12.12	3.41
Common Equity, 3 Yr. CAGR %	2.05	6.19	11.59	45.75	34.18
Cash From Operations, 3 Yr. CAGR %	14.47	0.86	-11.35	-5.4	7.61
Capital Expenditures, 3 Yr. CAGR %	0.66	-8.49	-0.91	6.61	14.21
Levered Free Cash Flow, 3 Yr. CAGR %	14.46	50.57	58.25	-9.13	-18.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	-8.43	45.37	37.53	12.57	-15.27
Dividend Per Share, 3 Yr. CAGR %	9.06	2.82	1.77	1.37	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.98	3.05	-0.57	2.78	9.86
Gross Profit, 5 Yr. CAGR %	3.75	3.55	-1.71	-5.17	8.96
EBITDA, 5 Yr. CAGR %	7.86	8.42	-0.32	-26.73	4.47
EBITA, 5 Yr. CAGR %	11.32	10.27	-0.96	-42.73	2.8
EBIT, 5 Yr. CAGR %	13.74	10.36	-3.94	-14.27	-8.81
Earnings From Cont. Operations, 5 Yr. CAGR %	20.22	10.64	-23.23	-10.03	-16.48
Net Income, 5 Yr. CAGR %	41.88	21.97	-0.79	14.69	-19.9
Normalized Net Income, 5 Yr. CAGR %	19.25	15.41	-1.89	-7.7	-14.14
Diluted EPS Before Extra, 5 Yr. CAGR %	21.05	11.13	-23.59	-14.18	-24.44
Accounts Receivable, 5 Yr. CAGR %	0.62	1.28	-0.44	10.14	10.21
Inventory, 5 Yr. CAGR %	2.92	5	4.83	11.21	10.26
Net Property, Plant and Equip., 5 Yr. CAGR %	3.54	3.54	1.54	9.59	7.22
Total Assets, 5 Yr. CAGR %	4.11	4.32	6.33	20.23	20.21
Tangible Book Value, 5 Yr. CAGR %	4.94	6.8	7.47	-2.33	1.01
Common Equity, 5 Yr. CAGR %	5.95	8.94	9.06	24.1	23.83
Cash From Operations, 5 Yr. CAGR %	16.51	6.99	-0.63	-1.88	5.12
Capital Expenditures, 5 Yr. CAGR %	0	0.95	2.42	-0.36	4.4
Levered Free Cash Flow, 5 Yr. CAGR %	-8.87	29.9	32.62	-13.29	29.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	-16.97	26.1	19.93	-9.14	25.71
Dividend Per Share, 5 Yr. CAGR %	7.78	7.39	6.46	1.68	0.82